Sustainability & Climate

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

As EBONY marks its 80th anniversary, the iconic Power 100 list returns with public nominations, aiming to redefine influence and celebrate a new generation.

Brunswick's Freedom Boat Club just bought its largest franchise, signaling a strategic consolidation and a major bet on the 'boating-as-a-service' model.

At AACR 2026, CREATE Medicines debuts its RetroT platform, an all-RNA system for stable gene delivery that avoids viral vectors and reshapes cell therapy.

Sideline Group raises $155M to invest in real-world experiences, signaling a major shift from digital-first ventures to the booming 'offline' economy.

The performance fabric giant launches a new program offering exclusive pricing, simplified ordering, and unique collaborations to interior design professionals.

After a three-year, $200M+ transformation, Napa's legendary Robert Mondavi Winery reopens, blending heritage with high-tech to redefine luxury wine.

With $16M in new funding and landmark trial results, ScreenPoint Medical is poised to redefine breast cancer screening with its powerful AI technology.

Preliminary Q1 data from Auna shows rising demand for specialized care in Peru, Colombia, and Mexico, offering investors a transparent new look.

With a $100M deal for UK's UDlive, Badger Meter is building a global powerhouse to tackle aging pipes, overflows, and climate change with smart tech.

With the appointment of a new CTO, ChronicCareIQ signals a major push into AI to scale its platform and revolutionize chronic disease management.

The ACORYS® system offers a non-invasive, real-time, four-chamber heart view, promising to revolutionize arrhythmia treatment and challenge market leaders.

Beijing's TICSSO-4 conference reveals how single-cell and spatial omics, powered by AI, are accelerating a new era in personalized healthcare.

Hitting one million sales faster than any brand in history, Chery's OMODA & JAECOO are set to unveil new hybrid tech and a 'cyber-mecha' SUV.

Biotech veteran Habib Dable, who led Acceleron to an $11.5B Merck sale, joins Tyra Biosciences' board, signaling a major push toward commercialization.

In a major consolidation, Red Wheel/Weiser acquires Watkins Publishing, uniting two spiritual publishing legends and navigating a complex industry landscape.

GCAPP's five-year plan transforms adolescent health in Georgia, reaching hundreds of thousands and setting the stage for its next ambitious chapter.

Byondis presents two novel ADC platforms at AACR 2026, aiming to solve drug resistance and offer hope for patients unresponsive to immunotherapy.

As clinicians flee traditional medicine, Ultralight's AI platform gets $9.3M to build the operating system for a new era of root-cause healthcare.

Geviti Health has launched a first-of-its-kind free AI platform to analyze bloodwork, promising to make preventative health more accessible than ever.